• Newsletter
  • Subscribe
  • Log In
  • Corporate
  • DONATE
  • LinkedIn
  • X
The Global Health Report
  • Policy
  • Companies
  • Research
  • People
  • AI
Hot Topics
  • March 9, 2026 | Real-time data on global dengue outbreaks
  • November 5, 2025 | Davos brain health plan hopes to unlock Africa funds
  • October 31, 2025 | GSK’s Q3 results buoyed by long-acting HIV jab
  • October 27, 2025 | South Africa to make Gilead’s lenacapavir a ‘public good’
  • October 24, 2025 | Sanofi Global Health Unit says 1 mln reached since 2021
The Global Dengue Observatory provides an estimate of the current global dengue situation. Image courtesy of Global Dengue Observatory

Disease March 9, 2026

Real-time data on global dengue outbreaks

A global information service launched last week gives a real time snapshot of global dengue outbreaks across 88 countries. The Global Dengue Observatory, developed by…

Read More
Wider use of existing brain health treatments could add $6.2 trillion to global economic output every year from 2050.

Policy

Davos brain health plan hopes to unlock Africa funds

Strong performance in its long-acting HIV preventable has helped GlaxoSmithKline to raise its profit forecasts

Companies

GSK’s Q3 results buoyed by long-acting HIV jab

South Africa's Minister of Health Aaron Motsoaledi said the country plans to make Gilead’s twice-yearly HIV preventative lenacapavir into a 'public good'

Policy

South Africa to make Gilead’s lenacapavir a ‘public good’

Sanofi has created a brand of affordable drugs for NCD patients called Impact, tackling cardiovascular diseases, cancers, and diabetes

Companies

Sanofi Global Health Unit says 1 mln reached since 2021

At the Seventh Replenishment summit in 2022, the US committed $6 billion, out of a record $15 billion raised.

Companies

Viiv/GSK pledge $8 mln ahead of Global Fund summit

Colorized scanning electron micrograph showing carbapenem-resistant Klebsiella pneumoniae. Image Wikimedia Commons

Uncategorised

‘Especially concerning’ AMR data for Africa – WHO

Vaccines are being designed with the help of AI.

Research

AI being used to create vaccines for future pandemic

The long-acting HIV prevention jab cabotegravir has a higher acceptability rating among patients than lenacapavir, according to a study.

Research

Patients prefer ViiV’s PrEP jab over Gilead’s – study

Two private equity firms bidding for Bavarian Nordic have increased their offer for the Danish maker of vaccines for mpox, cholera and chikungunya.

Companies October 15, 2025

Suitors up price for Bavarian Nordic

Two private equity firms bidding for Bavarian Nordic have increased their offer for the Danish maker of vaccines for mpox, cholera and chikungunya, after shareholders…

1 2 3 »

Most Viewed

  • The US has so far funded a third of the cost of fighting mpox.US aid suspension threatens mpox fight
  • Uganda has started the world’s biggest malaria vaccination campaign.Uganda launches largest-ever malaria vaccine drive
  • African countries are at risk of missing out on flu jabs in the case of a pandemic, according to the latest study from the WHO.Africa could miss out in a pandemic – study
  • The world is off track to meet the health-related SDGs, amid a darkening geopolitical outlook for health spending.World off-track to meet health SDGs – WHO
  • South Africa's Minister of Health Aaron Motsoaledi said the country plans to make Gilead’s twice-yearly HIV preventative lenacapavir into a 'public good'South Africa to make Gilead’s lenacapavir a ‘public good’
  • Privacy Policy
  • Account
  • About us

Copyright 2026 | MH Newsdesk by MH Themes

Receive our weekly briefing on AI in global health

From our team of writers around the world

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.